- Home
- Publications
- Publication Search
- Publication Details
Title
MYC dysregulation in the progression of multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-23
DOI
10.1038/s41375-019-0543-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
- (2019) Benjamin G. Barwick et al. Nature Communications
- Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
- (2018) Ankit K. Dutta et al. LEUKEMIA
- The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
- (2017) Aneta Mikulasova et al. HAEMATOLOGICA
- The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
- (2017) Aneta Mikulasova et al. HAEMATOLOGICA
- MYC Deregulation in Primary Human Cancers
- (2017) Manpreet Kalkat et al. Genes
- MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma
- (2016) Dongxue Wang et al. NUCLEIC ACIDS RESEARCH
- Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
- (2016) Aurélie Kamoun et al. Nature Communications
- Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients
- (2016) K M Kortuem et al. Blood Cancer Journal
- Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
- (2015) N. Weinhold et al. HAEMATOLOGICA
- Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
- (2015) N. Weinhold et al. HAEMATOLOGICA
- Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma
- (2014) M Affer et al. LEUKEMIA
- Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
- (2014) B A Walker et al. Blood Cancer Journal
- MAX Inactivation in Small Cell Lung Cancer Disrupts MYC-SWI/SNF Programs and Is Synthetic Lethal with BRG1
- (2013) O. A. Romero et al. Cancer Discovery
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More